www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Urgent: Prodi's government wins confidence vote    Chinese Premier orders thorough probe of fake drug incident     Thaksin ready to return after "political break"    Denmark confirms first bird-flu outbreak in poultry    UN urges U.S. to close secret prisons abroad, in Guantanamo     Villagers take 2 teachers hostage in S. Thailand    
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
RSS  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Online marketplace of Manufacturers & Wholesalers
   News Photos Voice People BizChina Feature About us   
5 drugs of Heilongjiang drug maker proved fake
www.chinaview.cn 2006-05-19 20:12:53

    BEIJING, May 19 (Xinhua) -- Five drugs made by a Chinese pharmaceutical company have been proved fake, including an injection fluid that killed five people in a month, Friday's Beijing News reported.

    Five people died and six others were hospitalized after they received a drug called Armillarisni A for gallbladder inflammation that contained the chemical, diglycol, that can cause kidney failure, said China's State Food and Drug Administration on Friday.

    The counterfeit ingredient was also found in another four drugs produced by Qiqihar No. 2 Pharmaceutical Co. Ltd. in China's northeastern Heilongjiang province.

    The company has been shut down and its products banned while police has detained a drug dealer named Wang Guiping who sold diglycol to the company.

    In Beijing, the government has sealed up over 6,000 boxes of eight drugs from the company though it has received no reports of negative reactions. Enditem

Editor: Lu Hui
  Related Story  
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.